Immuron taking forward new therapy for fatty liver disease
23 August 2011
Ian Haydock
Please Login to read the full article.
23 August 2011
Ian Haydock
ian.haydock@informa.com
Please Login to read the full article.
RELATED CONTENT
NEWS
- Genfit progresses dual PPAR agonist for liver disease associated with diabetes
- EU fidaxomicin approval another feather in Optimer's 2011 cap
- Amylin seeking first US approval for lipodystrophy with metreleptin
- US Capitol Capsule: Hope not enough for Avastin in MBC; Hamburg explains withdrawal
EVENTS
07 June 2012
The Rembrandt Hotel, London
12 June 2012
Annecy, France
18 June 2012
Boston Convention & Exhibition Center, Boston, MA
JOB OF THE WEEK
Section Head (m/f)
DRA International/CIS Section
Section Head (m/f)
DRA International/CIS Section
